Clinical Trial Update: Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the combination of erlotinib and sorafenib in chemonaive patients with locally advanced or metastatic non-small cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nexavar (Sorafenib)
• Tarceva (erlotinib)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN